Uganda – FY 2010 Approved Funding by Program Area, Agency and Funding Source*
*Only appropriations from the GHCS (State) fund account are notified by the Global AIDS Coordinator.
With FY 2010 funding, PEPFAR will place increased focus on sexual and biomedical prevention programming in Uganda. Since the most common means of HIV transmission is unprotected sex, particularly through discordant couples and CSWs and their partners, PEPFAR will focus programming around “personalized risk.” To overcome barriers to condom use, PEPFAR will support procurement, quality testing, and logistics management of condoms for free distribution and social marketing. PEPFAR will also promote increased HCT. PEPFAR will increase access to HCT services for couples and MARPs and specifically address sexual norms among MARPs. To deepen PMTCT services, primary prevention and preventing unwanted pregnancies will receive special attention.
Biomedical prevention programming will support the completion and implementation of the national blood transfusion safety strategic plan and support the MOH to strengthen injection safety practices. Based on a comprehensive review of Uganda’s prevention portfolio, increased resources will be allocated for VMMC service delivery and clinical training to accelerate the pace of scale-up of this proven prevention intervention. The Ugandan People’s Defense Force will increase the number of its fully equipped VMMC sites from four to six and significantly increase the number of military personnel targeted for VMMC.
Care services are in high demand in Uganda, with over 360,000 PLWHA receiving PEPFAR -supported care as of March 2009. In FY 2010, PEPFAR will rationalize care services, reduce duplication, and work closely with district health management teams to use resources more efficiently. PEPFAR will continue to strengthen linkages among services such as HCT, PMTCT, EID, PwP, and orphan care. PEPFAR will also integrate HIV/TB activities, strengthen the surveillance and management of MDR-TB, and help complete the national TB Drug Resistance Survey. PEPFAR will continue to support a strong family and community response for Uganda’s OVC.
In FY 2010, PEPFAR will continue to support treatment for these patients and will place increased emphasis on raising pediatric ART coverage. PEPFAR will also provide critical TA to strengthen the MOH's forecasting and procurement capability, thereby preventing ARV stock-outs and emergency procurements. Thirty-six laboratories will be renovated and PEPFAR will support the MOH in defining standards for laboratory equipment.
A renewed focus on HSS contributed to a 50% rise in Uganda’s funding allocation in FY 2010; this funding will focus largely in the areas of HRH, HMIS, improving governance and leadership, and supply chain management. Funds will also continue to ensure program monitoring and accountability, ensure PEPFAR policy and technical leadership within the Ugandan national response, and cover compensation, logistics, and office and administrative costs.
Over the past year, PEPFAR achieved considerable success in integration within its laboratory programs, ensuring that PEPFAR’s support for QA is applied across all lab activities—not just those related to HIV. As a result, the quality of lab services for all diseases has improved.
To address issues of cost effectiveness, in FY 2009 PEPFAR carried out a procurement rationalization process that dramatically reduced the number of drug procurement mechanisms and increased use of generic drugs. In addition, PEPFAR continued to reap the benefits of past investments and made solid progress in both PMTCT and TB/HIV.
Additionally, funding will support the purchase of ARVs for use in the PEPFAR treatment program in Uganda. Supplementary ARVs will refill buffer stocks, prevent stockouts, and allow for continued expansion of treatment services through the remainder of FY 2010 and into early FY 2011.
| U.S. Government interagency website managed by the Office of U.S. Global AIDS Coordinator|
and the Bureau of Public Affairs, U.S. State Department.
External Link Policy | Copyright Information | Privacy | FOIA